Julie Holihan, MD
Surgery · Houston, TXNPI 1407101157
Payments from drug & device makers
Across 167 payments — averaging $416.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$28K
- Distalmotion US$16K
- W. L. Gore & Associates, Inc.$14K
- Medtronic$3K
- TELA Bio, Inc.$2K
- Davol Inc.$1K
- plus $4K from 15 others
What the payments were for
- Consulting fees$10,00017%
- Travel & lodging$12,35021%
- Food & beverage$10,46418%
- Education$24,97043%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 40 | $28,470 |
| Distalmotion US | 13 | $16,444 |
| W. L. Gore & Associates, Inc. | 23 | $14,054 |
| Medtronic | 16 | $3,013 |
| TELA Bio, Inc. | 11 | $1,864 |
| Davol Inc. | 12 | $1,499 |
| AbbVie(2 entities) | 16 | $1,383 |
| Baxter Healthcare | 12 | $795 |
| Johnson & Johnson | 5 | $554 |
| Integra Lifesciences Corporation | 5 | $385 |
| Smith+Nephew | 2 | $224 |
| Boston Scientific | 1 | $157 |
| Kerecis Limited | 1 | $154 |
| Stryker | 1 | $118 |
| Olympus America Inc. | 1 | $90 |
| Acera Surgical, Inc. | 1 | $81 |
| Covidien LP | 1 | $75 |
| Acell, Inc. | 2 | $45 |
| BD | 1 | $44 |
| Shire North American Group Inc | 2 | $39 |
| KCI USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$26,396
- DEXTER L6 ROBOT$16,242
- DAVINCI XI$1,000
- OviTex 2S$1,000
- GORE BIO-A Tissue Reinforcement$872
- Kerecis Omega3 Marigen$615
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$528
- Signia$499
- PHASIX$404
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$396
- GORE ENFORM Preperitoneal Biomaterial$296
- GORE SYNECOR Biomaterial$277
- VISTASEAL$271
- PerClot$267
- ALLODERM$258
- INTEGRA$254
- SEAMGUARD Staple Line Reinforcement$219
- Phasix Mesh$159
- SpyGlass Discover$157
- Kerecis Omega3 SurgiClose$154
How this compares
$69,507 in reported general payments places this provider in the 90th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 36 | $242 |
| Sucralfate | 12 | $136 |
| Tramadol Hcl | 20 | $27 |
Paid to pharmacies, not to this prescriber.
Other surgery in Houston
- Funda MericHouston$20.6M
- Isidoro WienerHouston$850K
- Mark HobeikaHouston$462K
- Joseph CoselliHouston$382K
- James SuliburkHouston$161K
- Richard KnightHouston$147K
- Michael HarkinsTomball$2.7M
- Lloyd StegemannCorpus Christi$1.9M
- Douglas StoddardAustin$1.4M
- Erik WilsonBellaire$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.